TREATMENT OUTCOMES IN MODERATELY LEAD TOXIC CHILDREN

中度铅中毒儿童的治疗结果

基本信息

  • 批准号:
    3251889
  • 负责人:
  • 金额:
    $ 44.88万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1986
  • 资助国家:
    美国
  • 起止时间:
    1986-03-01 至 1993-01-31
  • 项目状态:
    已结题

项目摘要

The long-term goal of the proposed research is to ameliorate the harmful effects of increased lead (Pb) absorption in children. To this end, we will continue to assess the biochemical and functional consequences of moderate body burdens of Pb in young children within a comprehensive clinical research program focused on the effects of chelation treatment. Our multidisciplinary approach focuses on the relationships between body burden of Pb and three types of outcomes. Body Pb burden is being measured in three ways: 1) blood Pb concentrations, an index of recent exposure; 2) urinary Pb excretion during CaNa2 EDTA testing, an index of mobilzable Pb stores; and 3) L x-ray fluorescence determination of bone Pb, a direct, non-invasive and quantitative measure of bone Pb that has accumulated over time. The outcome measures are those which are affected by lead burden. these include: 1) biochemical abnormalities -- erythrocyte protoporphyrin levels (EP) in whole blood and 1,25- dihydroxyvitamin D (1,25-(OH)2D) and osteocalcin concentrations in serum; 2) central nervous system dysfunction as indexed by auditory and somatosensory evoked potentials; and 3) behavioral deficits as reflected by global measures of intelligence in addition to specific measures of attention and reaction time. A pre-/post-treatment design is permitting us to describe the effects of treatment on multiple outcomes over time, to make inferences about the effects of moderate Pb toxicity on children's brain function and behavior, and to explore different means by which Pb exerts its toxic effects.
拟议研究的长期目标是改善有害的

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOHN F ROSEN其他文献

JOHN F ROSEN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOHN F ROSEN', 18)}}的其他基金

TREATMENT OUTCOMES IN MODERATELY LEAD TOXIC CHILDREN
中度铅中毒儿童的治疗结果
  • 批准号:
    3251888
  • 财政年份:
    1986
  • 资助金额:
    $ 44.88万
  • 项目类别:
TREATMENT OUTCOMES IN MODERATELY LEAD TOXIC CHILDREN
中度铅中毒儿童的治疗结果
  • 批准号:
    3251879
  • 财政年份:
    1986
  • 资助金额:
    $ 44.88万
  • 项目类别:
TREATMENT OUTCOMES IN MODERATELY LEAD TOXIC CHILDREN
中度铅中毒儿童的治疗结果
  • 批准号:
    3251883
  • 财政年份:
    1986
  • 资助金额:
    $ 44.88万
  • 项目类别:
TREATMENT OUTCOMES IN MODERATELY LEAD TOXIC CHILDREN
中度铅中毒儿童的治疗结果
  • 批准号:
    3251884
  • 财政年份:
    1986
  • 资助金额:
    $ 44.88万
  • 项目类别:
TREATMENT OUTCOMES IN MODERATELY LEAD TOXIC CHILDREN
中度铅中毒儿童的治疗结果
  • 批准号:
    3251887
  • 财政年份:
    1986
  • 资助金额:
    $ 44.88万
  • 项目类别:
TREATMENT OUTCOMES IN MODERATELY LEAD TOXIC CHILDREN
中度铅中毒儿童的治疗结果
  • 批准号:
    3251886
  • 财政年份:
    1986
  • 资助金额:
    $ 44.88万
  • 项目类别:
TREATMENT OUTCOMES IN MODERATELY LEAD TOXIC CHILDREN
中度铅中毒儿童的治疗结果
  • 批准号:
    3251885
  • 财政年份:
    1986
  • 资助金额:
    $ 44.88万
  • 项目类别:
TREATMENT OUTCOMES IN MODERATELY LEAD TOXIC CHILDREN
中度铅中毒儿童的治疗结果
  • 批准号:
    3251880
  • 财政年份:
    1986
  • 资助金额:
    $ 44.88万
  • 项目类别:
METABOLISM OF LEAD IN BONE
骨中铅的代谢
  • 批准号:
    2153030
  • 财政年份:
    1977
  • 资助金额:
    $ 44.88万
  • 项目类别:
THE METABOLISM OF LEAD IN BONE
铅在骨中的代谢
  • 批准号:
    3483748
  • 财政年份:
    1977
  • 资助金额:
    $ 44.88万
  • 项目类别:

相似海外基金

Novel oxime antidotes for an organophosphate insecticide requiring bioactivation
用于需要生物活化的有机磷杀虫剂的新型肟解毒剂
  • 批准号:
    10629574
  • 财政年份:
    2023
  • 资助金额:
    $ 44.88万
  • 项目类别:
Development of small molecule inhibitors as anti-inflammatory agents and antidotes for arsenicals
开发作为抗炎剂和砷解毒剂的小分子抑制剂
  • 批准号:
    10727507
  • 财政年份:
    2023
  • 资助金额:
    $ 44.88万
  • 项目类别:
Dual cavity baskets as nano antidotes for overdose with fentanyl and its derivatives
双腔篮作为芬太尼及其衍生物过量服用的纳米解毒剂
  • 批准号:
    10369058
  • 财政年份:
    2021
  • 资助金额:
    $ 44.88万
  • 项目类别:
Antidotes against HCI-induced chronic lung injury
针对 HCI 引起的慢性肺损伤的解毒剂
  • 批准号:
    10015581
  • 财政年份:
    2020
  • 资助金额:
    $ 44.88万
  • 项目类别:
Antidotes against HCI-induced chronic lung injury
针对 HCI 引起的慢性肺损伤的解毒剂
  • 批准号:
    10241958
  • 财政年份:
    2020
  • 资助金额:
    $ 44.88万
  • 项目类别:
Hemoglobin-based antidotes for the treatment of carbon monoxide poisoning
用于治疗一氧化碳中毒的血红蛋白解毒剂
  • 批准号:
    10282997
  • 财政年份:
    2020
  • 资助金额:
    $ 44.88万
  • 项目类别:
Antidotes against HCI-induced chronic lung injury
针对 HCI 引起的慢性肺损伤的解毒剂
  • 批准号:
    10471329
  • 财政年份:
    2020
  • 资助金额:
    $ 44.88万
  • 项目类别:
Hemoglobin-based antidotes for the treatment of carbon monoxide poisoning
用于治疗一氧化碳中毒的血红蛋白解毒剂
  • 批准号:
    10296690
  • 财政年份:
    2020
  • 资助金额:
    $ 44.88万
  • 项目类别:
Hemoglobin-based antidotes for the treatment of carbon monoxide poisoning
用于治疗一氧化碳中毒的血红蛋白解毒剂
  • 批准号:
    9908358
  • 财政年份:
    2020
  • 资助金额:
    $ 44.88万
  • 项目类别:
Antidotes for Acute Cannabinoid Intoxication
急性大麻素中毒的解毒剂
  • 批准号:
    10460623
  • 财政年份:
    2018
  • 资助金额:
    $ 44.88万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了